unknown
Stage
About
Digit Bio develops molecular engineering technologies that enable high-resolution functional screening and characterization of biological medicines directly within cellular and tissue systems to optimize next-generation therapies.
Explore Digit Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.